Related Experiment Video
Updated: Jun 18, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Membranoproliferative glomerulonephritis
1Renal Unit, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
Abstract:
Membranoproliferative glomerulonephritis is an uncommon kidney disorder characterized by mesangial cell proliferation and structural changes in glomerular capillary walls. It can be subdivided into idiopathic and secondary forms, which are differentially diagnosed by a review of clinical features, laboratory data, and renal histopathology. Three types-I, II, and III-have been defined by pathologic features. All three types are associated with hypocomplementemia, but they manifest somewhat different mechanisms of complement activation. Type II, also known as "dense deposit disease", is associated with the presence of C3-nephritic factor. Membranoproliferative glomerulonephritis primarily affects children and young adults, with patients presenting with nephrotic or nephritic syndrome or with asymptomatic renal disease. This type of glomerulonephritis often progresses slowly to end-stage renal disease, and it tends to recur after renal transplantation, especially type II. The efficacy of various forms of treatment remains controversial; however, long-term steroid treatment seems to be effective in children with nephrotic-range proteinuria. Improvement in renal outcomes largely relies on the evaluation of more selective agents in carefully controlled studies.
Insights
Membranoproliferative glomerulonephritis (MPGN) is a rare kidney disease affecting young people. While treatments are debated, steroids may help children with nephrotic symptoms, and new therapies are needed for better outcomes.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Membranoproliferative glomerulonephritis (MPGN) is an uncommon kidney disorder.
- Characterized by mesangial cell proliferation and glomerular capillary wall changes.
- Subdivided into idiopathic and secondary forms, with three pathological types (I, II, III).
Purpose of the Study:
- To summarize the characteristics, diagnosis, and treatment of MPGN.
- To highlight the role of complement activation in different MPGN types.
- To discuss the prognosis and therapeutic challenges in MPGN.
Main Methods:
- Differential diagnosis relies on clinical features, laboratory data, and renal histopathology.
- Classification into types I, II, and III based on pathological findings.
- Analysis of complement activation pathways and clinical presentations.
Main Results:
- All MPGN types are associated with hypocomplementemia, with varying complement activation mechanisms.
- Type II MPGN (dense deposit disease) is linked to C3 nephritic factor.
- MPGN often affects children and young adults, presenting with nephrotic/nephritic syndrome or asymptomatic disease.
- Slow progression to end-stage renal disease and post-transplant recurrence (especially type II) are common.
Conclusions:
- Long-term steroid treatment may benefit children with nephrotic-range proteinuria.
- Treatment efficacy remains controversial, necessitating further research.
- Improved renal outcomes depend on evaluating more selective agents in controlled studies.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Nephrotic Syndrome I : Introduction
Diabetic Nephropathy
Glomerular Filtration: Net Filtration Pressure
GBHP, with an average value of 55 mmHg, promotes filtration by pushing water and solutes through the filtration membrane. This is balanced by two opposing forces: CHP, a "back pressure" exerted against the filtration membrane by fluid already in the capsular space and renal tubule,...
Acute Kidney Injury II: Pathophysiology
Streptococcal Pharyngitis

